Last 12 months
Inside the activity.
0 purchase rows · 116 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 6 |
| Jan 2026 | 0 | 5 |
| Feb 2026 | 0 | 17 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 23 |
| May 2026 | 0 | 15 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 5 |
| Sep 2026 | 0 | 41 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 31, 2025 Filed Nov 4, 2025 21:05 UTC |
Coughlin TimothyDirector
|
Exercise / conversionCommon Stock | 8,000 | $16.33 | $130,640.00 |
DisclosureSEC source: 0001376043-25-000004 · form4-11042025_041110.xml · nonDerivative · entry 1 Coughlin Timothy · CIK 0001376043 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 63,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 31, 2025 Filed Nov 4, 2025 21:05 UTC |
Heerma PeterCHIEF COMMERCIAL OFFICER
|
SaleCommon Stock | 5,591 | $35.00 | $195,685.00 |
DisclosureSEC source: 0001789617-25-000007 · form4-11042025_041108.xml · nonDerivative · entry 1 Heerma Peter · CIK 0001789617 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 119,071 F1 · kind: This sale was made pursuant to a written plan adopted on June 16, 2025, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended. Read SEC document |
| October 29, 2025 Filed Oct 30, 2025 20:45 UTC |
Dube Eric MDirector · CHIEF EXECUTIVE OFFICER
|
Exercise / conversionEmployee stock option (right to buy) · Derivative | 27,128 | $0.00 Strike: $15.46 | $0.00 |
DisclosureSEC source: 0001763494-25-000005 · form4-10302025_041004.xml · derivative · entry 6 Dube Eric M · CIK 0001763494 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 180,000 Underlying: Common Stock · 27,128 shares Expires 2030-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock option is fully vested and exercisable. Read SEC document |
| October 29, 2025 Filed Oct 30, 2025 20:45 UTC |
Dube Eric MDirector · CHIEF EXECUTIVE OFFICER
|
SaleCommon Stock | 27,128 | $30.12 | $817,073.66 |
DisclosureSEC source: 0001763494-25-000005 · form4-10302025_041004.xml · nonDerivative · entry 4 Dube Eric M · CIK 0001763494 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 419,173 F1 · kind: This sale was made pursuant to a written plan adopted on June 16, 2025, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended. F3 · price: The weighted average sale price for the transaction reported was $30.1192, and the range of prices were between $30.00 and $30.48. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided. Read SEC document |
| October 29, 2025 Filed Oct 30, 2025 20:45 UTC |
Dube Eric MDirector · CHIEF EXECUTIVE OFFICER
|
Exercise / conversionCommon Stock | 27,128 | $15.46 | $419,398.88 |
DisclosureSEC source: 0001763494-25-000005 · form4-10302025_041004.xml · nonDerivative · entry 3 Dube Eric M · CIK 0001763494 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 446,301 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 28, 2025 Filed Oct 30, 2025 20:45 UTC |
Dube Eric MDirector · CHIEF EXECUTIVE OFFICER
|
Exercise / conversionEmployee stock option (right to buy) · Derivative | 92,872 | $0.00 Strike: $15.46 | $0.00 |
DisclosureSEC source: 0001763494-25-000005 · form4-10302025_041004.xml · derivative · entry 5 Dube Eric M · CIK 0001763494 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 207,128 Underlying: Common Stock · 92,872 shares Expires 2030-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock option is fully vested and exercisable. Read SEC document |
| October 28, 2025 Filed Oct 30, 2025 20:45 UTC |
Dube Eric MDirector · CHIEF EXECUTIVE OFFICER
|
SaleCommon Stock | 92,872 | $30.38 | $2,821,358.49 |
DisclosureSEC source: 0001763494-25-000005 · form4-10302025_041004.xml · nonDerivative · entry 2 Dube Eric M · CIK 0001763494 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 419,173 F1 · kind: This sale was made pursuant to a written plan adopted on June 16, 2025, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended. F2 · price: The weighted average sale price for the transaction reported was $30.379, and the range of prices were between $30.00 and $30.97. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided. Read SEC document |
| October 28, 2025 Filed Oct 30, 2025 20:45 UTC |
Dube Eric MDirector · CHIEF EXECUTIVE OFFICER
|
Exercise / conversionCommon Stock | 92,872 | $15.46 | $1,435,801.12 |
DisclosureSEC source: 0001763494-25-000005 · form4-10302025_041004.xml · nonDerivative · entry 1 Dube Eric M · CIK 0001763494 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 512,045 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 28, 2025 Filed Oct 30, 2025 20:45 UTC |
Heerma PeterCHIEF COMMERCIAL OFFICER
|
SaleCommon Stock | 2,662 | $30.00 | $79,860.00 |
DisclosureSEC source: 0001789617-25-000006 · form4-10302025_041001.xml · nonDerivative · entry 1 Heerma Peter · CIK 0001789617 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 124,662 F1 · kind: This sale was made pursuant to a written plan adopted on June 16, 2025, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended. Read SEC document |
| September 23, 2025 Filed Sep 24, 2025 20:05 UTC |
Heerma PeterCHIEF COMMERCIAL OFFICER
|
GiftCommon Stock | 891 | $0.00 | $0.00 |
DisclosureSEC source: 0001789617-25-000004 · form4-09242025_040905.xml · nonDerivative · entry 1 Heerma Peter · CIK 0001789617 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 127,324 F1 · kind: This transaction represents a charitable gift of 891 shares of common stock to a donor advised fund, which was gifted pursuant to a written plan adopted on June 16, 2025, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended. Read SEC document |
| September 22, 2025 Filed Sep 24, 2025 20:05 UTC |
REED ELIZABETH EChief Legal Officer and GC
|
Exercise / conversionEmployee stock option (right to buy) · Derivative | 10,000 | $0.00 Strike: $19.08 | $0.00 |
DisclosureSEC source: 0001283303-25-000005 · form4-09242025_040903.xml · derivative · entry 3 REED ELIZABETH E · CIK 0001283303 · Chief Legal Officer and GC 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 10,000 shares Expires 2027-01-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock option is fully vested and exercisable. Read SEC document |
| September 22, 2025 Filed Sep 24, 2025 20:05 UTC |
REED ELIZABETH EChief Legal Officer and GC
|
SaleCommon Stock | 10,000 | $25.00 | $250,000.00 |
DisclosureSEC source: 0001283303-25-000005 · form4-09242025_040903.xml · nonDerivative · entry 2 REED ELIZABETH E · CIK 0001283303 · Chief Legal Officer and GC 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 89,878 F2 · kind: This sale was made pursuant to a written plan adopted on June 16, 2025, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and consists of the sale of shares underlying a stock option grant to the Reporting Person on January 4, 2017 with an expiration date of January 4, 2027. Read SEC document |
| September 22, 2025 Filed Sep 24, 2025 20:05 UTC |
REED ELIZABETH EChief Legal Officer and GC
|
Exercise / conversionCommon Stock | 10,000 | $19.08 | $190,800.00 |
DisclosureSEC source: 0001283303-25-000005 · form4-09242025_040903.xml · nonDerivative · entry 1 REED ELIZABETH E · CIK 0001283303 · Chief Legal Officer and GC 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 99,878 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 396 shares acquired under the Issuer's 2017 Employee Stock Purchase Plan on May 31, 2025. Read SEC document |
| September 04, 2025 Filed Sep 5, 2025 20:05 UTC |
Cline Christopher R.CHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 119 | $19.71 | $2,345.49 |
DisclosureSEC source: 0001415889-25-023786 · form4-09052025_040901.xml · nonDerivative · entry 2 Cline Christopher R. · CIK 0001943192 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 92,083 F2 · kind: This sale was made pursuant to a written plan adopted on May 28, 2025, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and includes the sale of shares to cover the tax obligation that occurred upon the vesting of restricted stock units. Read SEC document |
| September 03, 2025 Filed Sep 5, 2025 20:05 UTC |
Cline Christopher R.CHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 454 | $18.20 | $8,262.80 |
DisclosureSEC source: 0001415889-25-023786 · form4-09052025_040901.xml · nonDerivative · entry 1 Cline Christopher R. · CIK 0001943192 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 92,202 F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover the tax withholding obligation in connection with the settlement of vested restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the Reporting Person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the Reporting Person. Read SEC document |
| August 27, 2025 Filed Aug 28, 2025 20:05 UTC |
Cline Christopher R.CHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 470 | $17.31 | $8,135.70 |
DisclosureSEC source: 0001415889-25-023209 · form4-08282025_040801.xml · nonDerivative · entry 1 Cline Christopher R. · CIK 0001943192 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 92,656 F1 · kind: This sale was made pursuant to a written plan adopted on May 28, 2025, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and includes the sale of additional shares to cover the tax obligation that occurred upon the vesting of performance-based restricted stock units (PSUs) that vested in May 2025. Read SEC document |
| July 01, 2025 Filed Jul 2, 2025 21:28 UTC |
Inrig JulaCHIEF MEDICAL OFFICER
|
SaleCommon Stock | 815 | $14.65 | $11,939.75 |
DisclosureSEC source: 0001415889-25-019108 · form4-07022025_090753.xml · nonDerivative · entry 1 Inrig Jula · CIK 0001902368 · CHIEF MEDICAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 88,787 F1 · kind: This sale was made pursuant to a written plan adopted on March 15, 2024, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and includes the sale of additional shares to cover the tax obligation that occurred upon the vesting of performance-based restricted stock units (PSUs) that vested in February 2025. Read SEC document |
| May 15, 2025 Filed May 16, 2025 23:00 UTC |
LYONS GARY ADirector
|
GrantStock option (right to buy) · Derivative | 19,500 | $0.00 Strike: $21.15 | $0.00 |
DisclosureSEC source: 0001415889-25-013499 · form4-05162025_070509.xml · derivative · entry 2 LYONS GARY A · CIK 0001123343 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,500 Underlying: Common Stock · 19,500 shares Expires 2035-05-15 F1 · shares: Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program. F2 · derivative.exercise_date: The equity award vests over a one year period. Read SEC document |
| May 15, 2025 Filed May 16, 2025 23:00 UTC |
LYONS GARY ADirector
|
GrantCommon Stock | 6,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-013499 · form4-05162025_070509.xml · nonDerivative · entry 1 LYONS GARY A · CIK 0001123343 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,500 F1 · shares: Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program. F2 · shares: The equity award vests over a one year period. Read SEC document |
| May 15, 2025 Filed May 16, 2025 23:00 UTC |
Orwin John ADirector
|
GrantStock option (right to buy) · Derivative | 19,500 | $0.00 Strike: $21.15 | $0.00 |
DisclosureSEC source: 0001415889-25-013501 · form4-05162025_070513.xml · derivative · entry 2 Orwin John A · CIK 0001477384 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,500 Underlying: Common Stock · 19,500 shares Expires 2035-05-15 F1 · shares: Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program. F2 · derivative.exercise_date: The equity award vests over a one year period. Read SEC document |
| May 15, 2025 Filed May 16, 2025 23:00 UTC |
Orwin John ADirector
|
GrantCommon Stock | 6,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-013501 · form4-05162025_070513.xml · nonDerivative · entry 1 Orwin John A · CIK 0001477384 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,375 F1 · shares: Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program. F2 · shares: The equity award vests over a one year period. Read SEC document |
| May 15, 2025 Filed May 16, 2025 23:00 UTC |
Squarer RonDirector
|
GrantStock option (right to buy) · Derivative | 19,500 | $0.00 Strike: $21.15 | $0.00 |
DisclosureSEC source: 0001415889-25-013503 · form4-05162025_070517.xml · derivative · entry 2 Squarer Ron · CIK 0001454001 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,500 Underlying: Common Stock · 19,500 shares Expires 2035-05-15 F1 · shares: Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program. F2 · derivative.exercise_date: The equity award vests over a one year period. Read SEC document |
| May 15, 2025 Filed May 16, 2025 23:00 UTC |
Squarer RonDirector
|
GrantCommon Stock | 6,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-013503 · form4-05162025_070517.xml · nonDerivative · entry 1 Squarer Ron · CIK 0001454001 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,375 F1 · shares: Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program. F2 · shares: The equity award vests over a one year period. Read SEC document |
| May 15, 2025 Filed May 16, 2025 23:00 UTC |
Williams Brinkley RuthDirector
|
GrantStock option (right to buy) · Derivative | 19,500 | $0.00 Strike: $21.15 | $0.00 |
DisclosureSEC source: 0001415889-25-013504 · form4-05162025_070518.xml · derivative · entry 2 Williams Brinkley Ruth · CIK 0001344381 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,500 Underlying: Common Stock · 19,500 shares Expires 2035-05-15 F1 · shares: Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program. F2 · derivative.exercise_date: The equity award vests over a one year period. Read SEC document |
| May 15, 2025 Filed May 16, 2025 23:00 UTC |
Williams Brinkley RuthDirector
|
GrantCommon Stock | 6,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-013504 · form4-05162025_070518.xml · nonDerivative · entry 1 Williams Brinkley Ruth · CIK 0001344381 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,750 F1 · shares: Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program. F2 · shares: The equity award vests over a one year period. Read SEC document |
| May 15, 2025 Filed May 16, 2025 23:00 UTC |
Poole SandraDirector
|
GrantStock option (right to buy) · Derivative | 19,500 | $0.00 Strike: $21.15 | $0.00 |
DisclosureSEC source: 0001415889-25-013502 · form4-05162025_070515.xml · derivative · entry 2 Poole Sandra · CIK 0001619622 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,500 Underlying: Common Stock · 19,500 shares Expires 2035-05-15 F1 · shares: Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program. F2 · derivative.exercise_date: The equity award vests over a one year period. Read SEC document |
| May 15, 2025 Filed May 16, 2025 23:00 UTC |
Poole SandraDirector
|
GrantCommon Stock | 6,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-013502 · form4-05162025_070515.xml · nonDerivative · entry 1 Poole Sandra · CIK 0001619622 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 F1 · shares: Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program. F2 · shares: The equity award vests over a one year period. Read SEC document |
| May 15, 2025 Filed May 16, 2025 23:00 UTC |
Meckler Jeffrey ADirector
|
GrantStock option (right to buy) · Derivative | 19,500 | $0.00 Strike: $21.15 | $0.00 |
DisclosureSEC source: 0001415889-25-013500 · form4-05162025_070511.xml · derivative · entry 2 Meckler Jeffrey A · CIK 0001506916 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,500 Underlying: Common Stock · 19,500 shares Expires 2035-05-15 F1 · shares: Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program. F2 · derivative.exercise_date: The equity award vests over a one year period. Read SEC document |
| May 15, 2025 Filed May 16, 2025 23:00 UTC |
Meckler Jeffrey ADirector
|
GrantCommon Stock | 6,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-013500 · form4-05162025_070511.xml · nonDerivative · entry 1 Meckler Jeffrey A · CIK 0001506916 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,500 F1 · shares: Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program. F2 · shares: The equity award vests over a one year period. Read SEC document |
| May 15, 2025 Filed May 16, 2025 23:00 UTC |
Coughlin TimothyDirector
|
GrantStock option (right to buy) · Derivative | 19,500 | $0.00 Strike: $21.15 | $0.00 |
DisclosureSEC source: 0001415889-25-013498 · form4-05162025_070507.xml · derivative · entry 2 COUGHLIN TIMOTHY · CIK 0001376043 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,500 Underlying: Common Stock · 19,500 shares Expires 2035-05-15 F1 · shares: Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program. F2 · derivative.exercise_date: The equity award vests over a one year period. Read SEC document |
| May 15, 2025 Filed May 16, 2025 23:00 UTC |
Coughlin TimothyDirector
|
GrantCommon Stock | 6,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-013498 · form4-05162025_070507.xml · nonDerivative · entry 1 COUGHLIN TIMOTHY · CIK 0001376043 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,500 F1 · shares: Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program. F2 · shares: The equity award vests over a one year period. Read SEC document |
| May 15, 2025 Filed May 16, 2025 23:00 UTC |
Bruhn Suzanne LouiseDirector
|
GrantStock option (right to buy) · Derivative | 19,500 | $0.00 Strike: $21.15 | $0.00 |
DisclosureSEC source: 0001415889-25-013497 · form4-05162025_070505.xml · derivative · entry 2 Bruhn Suzanne Louise · CIK 0001517790 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,500 Underlying: Common Stock · 19,500 shares Expires 2035-05-15 F1 · shares: Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program. F2 · derivative.exercise_date: The equity award vests over a one year period. Read SEC document |
| May 15, 2025 Filed May 16, 2025 23:00 UTC |
Bruhn Suzanne LouiseDirector
|
GrantCommon Stock | 6,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-013497 · form4-05162025_070505.xml · nonDerivative · entry 1 Bruhn Suzanne Louise · CIK 0001517790 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,750 F1 · shares: Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program. F2 · shares: The equity award vests over a one year period. Read SEC document |
| May 15, 2025 Filed May 16, 2025 23:00 UTC |
Baynes Roy D.Director
|
GrantStock option (right to buy) · Derivative | 19,500 | $0.00 Strike: $21.15 | $0.00 |
DisclosureSEC source: 0001415889-25-013496 · form4-05162025_070503.xml · derivative · entry 2 Baynes Roy D. · CIK 0001680739 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,500 Underlying: Common Stock · 19,500 shares Expires 2035-05-15 F1 · shares: Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program. F2 · derivative.exercise_date: The equity award vests over a one year period. Read SEC document |
| May 15, 2025 Filed May 16, 2025 23:00 UTC |
Baynes Roy D.Director
|
GrantCommon Stock | 6,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-013496 · form4-05162025_070503.xml · nonDerivative · entry 1 Baynes Roy D. · CIK 0001680739 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,500 F1 · shares: Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program. F2 · shares: The equity award vests over a one year period. Read SEC document |
| May 05, 2025 Filed May 6, 2025 01:54 UTC |
Cline Christopher R.CHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 1,784 | $21.05 | $37,553.20 |
DisclosureSEC source: 0001415889-25-012061 · form4-05062025_010528.xml · nonDerivative · entry 2 Cline Christopher R. · CIK 0001943192 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,126 F3 · kind: Represents the number of shares required to be sold by the Reporting Person to cover the tax withholding obligation in connection with the settlement of vested performance restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the Reporting Person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the Reporting Person. Read SEC document |
| May 05, 2025 Filed May 6, 2025 01:53 UTC |
Dube Eric MDirector · CHIEF EXECUTIVE OFFICER
|
SaleCommon Stock | 18,924 | $21.05 | $398,350.20 |
DisclosureSEC source: 0001415889-25-012058 · form4-05062025_010542.xml · nonDerivative · entry 2 Dube Eric M · CIK 0001763494 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 419,173 F3 · kind: This sale was made pursuant to a written plan adopted on March 15, 2024 meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and includes the sale of shares to cover the tax obligation that occurred upon the vesting of performance restricted stock units. Read SEC document |
| May 05, 2025 Filed May 6, 2025 01:53 UTC |
Heerma PeterCHIEF COMMERCIAL OFFICER
|
SaleCommon Stock | 1,771 | $21.05 | $37,279.55 |
DisclosureSEC source: 0001415889-25-012057 · form4-05062025_010504.xml · nonDerivative · entry 2 Heerma Peter · CIK 0001789617 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 128,215 F3 · kind: Represents the number of shares required to be sold by the Reporting Person to cover the tax withholding obligation in connection with the settlement of vested performance restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the Reporting Person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the Reporting Person. Read SEC document |
| May 05, 2025 Filed May 6, 2025 01:52 UTC |
ROTE WILLIAM E.Chief Research Officer
|
SaleCommon Stock | 3,198 | $21.05 | $67,317.90 |
DisclosureSEC source: 0001415889-25-012056 · form4-05062025_010518.xml · nonDerivative · entry 2 ROTE WILLIAM E. · CIK 0001698262 · Chief Research Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 100,241 F3 · kind: This sale was made pursuant to a written plan adopted on March 15, 2024, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and includes the sale of shares to cover the tax obligation that occurred upon the vesting of performance restricted stock units. Read SEC document |
| May 05, 2025 Filed May 6, 2025 01:51 UTC |
REED ELIZABETH EChief Legal Officer and GC
|
SaleCommon Stock | 4,920 | $21.05 | $103,566.00 |
DisclosureSEC source: 0001415889-25-012054 · form4-05062025_010531.xml · nonDerivative · entry 2 REED ELIZABETH E · CIK 0001283303 · Chief Legal Officer and GC 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 89,482 F3 · kind: This sale was made pursuant to a written plan adopted on March 15, 2024, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and includes the sale of shares to cover the tax obligation that occurred upon the vesting of performance restricted stock units. Read SEC document |
| May 02, 2025 Filed May 6, 2025 01:54 UTC |
Cline Christopher R.CHIEF FINANCIAL OFFICER
|
Exercise / conversionPerformance-based restricted stock units · Derivative | 4,920 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-012061 · form4-05062025_010528.xml · derivative · entry 3 Cline Christopher R. · CIK 0001943192 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,920 Underlying: Common Stock · 4,920 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each PSU represents a contingent right to receive one share of the Common Stock of the Issuer. F1 · kind: On September 1, 2022, the reporting person was granted performance restricted stock units (PSUs) covering 9,840 shares of the Issuer's common stock, to vest upon the satisfaction of certain performance criteria. On May 2, 2025, 50% of the PSUs vested upon the Issuer's confirmation following the release of its financial results for the quarter ended March 31, 2025 that a performance criterion related to cumulative FILSPARI net revenue had been achieved. F1 · derivative.exercise_date: On September 1, 2022, the reporting person was granted performance restricted stock units (PSUs) covering 9,840 shares of the Issuer's common stock, to vest upon the satisfaction of certain performance criteria. On May 2, 2025, 50% of the PSUs vested upon the Issuer's confirmation following the release of its financial results for the quarter ended March 31, 2025 that a performance criterion related to cumulative FILSPARI net revenue had been achieved. F1 · derivative.expiration_date: On September 1, 2022, the reporting person was granted performance restricted stock units (PSUs) covering 9,840 shares of the Issuer's common stock, to vest upon the satisfaction of certain performance criteria. On May 2, 2025, 50% of the PSUs vested upon the Issuer's confirmation following the release of its financial results for the quarter ended March 31, 2025 that a performance criterion related to cumulative FILSPARI net revenue had been achieved. Read SEC document |
| May 02, 2025 Filed May 6, 2025 01:54 UTC |
Cline Christopher R.CHIEF FINANCIAL OFFICER
|
Exercise / conversionCommon Stock | 4,920 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-25-012061 · form4-05062025_010528.xml · nonDerivative · entry 1 Cline Christopher R. · CIK 0001943192 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,910 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: On September 1, 2022, the reporting person was granted performance restricted stock units (PSUs) covering 9,840 shares of the Issuer's common stock, to vest upon the satisfaction of certain performance criteria. On May 2, 2025, 50% of the PSUs vested upon the Issuer's confirmation following the release of its financial results for the quarter ended March 31, 2025 that a performance criterion related to cumulative FILSPARI net revenue had been achieved. F2 · price: Each PSU represents a contingent right to receive one share of the Common Stock of the Issuer. Read SEC document |
| May 02, 2025 Filed May 6, 2025 01:53 UTC |
Dube Eric MDirector · CHIEF EXECUTIVE OFFICER
|
Exercise / conversionPerformance-based restricted stock units · Derivative | 18,924 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-012058 · form4-05062025_010542.xml · derivative · entry 3 Dube Eric M · CIK 0001763494 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 18,924 Underlying: Common Stock · 18,924 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each performance-based restricted stock unit represents a contingent right to receive one share of the Common Stock of the Issuer. F1 · derivative.exercise_date: On January 31, 2022, the reporting person was granted performance restricted stock units (PSUs) covering 37,848 shares of the Issuer's common stock, to vest upon the satisfaction of certain performance criteria. On May 2, 2025, 50% of the PSUs vested upon the Issuer's confirmation following the release of its financial results for the quarter ended March 31, 2025 that a performance criterion related to cumulative FILSPARI net revenue had been achieved. F1 · derivative.expiration_date: On January 31, 2022, the reporting person was granted performance restricted stock units (PSUs) covering 37,848 shares of the Issuer's common stock, to vest upon the satisfaction of certain performance criteria. On May 2, 2025, 50% of the PSUs vested upon the Issuer's confirmation following the release of its financial results for the quarter ended March 31, 2025 that a performance criterion related to cumulative FILSPARI net revenue had been achieved. Read SEC document |
| May 02, 2025 Filed May 6, 2025 01:53 UTC |
Dube Eric MDirector · CHIEF EXECUTIVE OFFICER
|
Exercise / conversionCommon Stock | 18,924 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-25-012058 · form4-05062025_010542.xml · nonDerivative · entry 1 Dube Eric M · CIK 0001763494 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 438,097 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: On January 31, 2022, the reporting person was granted performance restricted stock units (PSUs) covering 37,848 shares of the Issuer's common stock, to vest upon the satisfaction of certain performance criteria. On May 2, 2025, 50% of the PSUs vested upon the Issuer's confirmation following the release of its financial results for the quarter ended March 31, 2025 that a performance criterion related to cumulative FILSPARI net revenue had been achieved. F2 · price: Each performance-based restricted stock unit represents a contingent right to receive one share of the Common Stock of the Issuer. Read SEC document |
| May 02, 2025 Filed May 6, 2025 01:53 UTC |
Heerma PeterCHIEF COMMERCIAL OFFICER
|
Exercise / conversionPerformance-based restricted stock units · Derivative | 4,920 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-012057 · form4-05062025_010504.xml · derivative · entry 3 Heerma Peter · CIK 0001789617 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,920 Underlying: Common Stock · 4,920 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each PSU represents a contingent right to receive one share of the common stock of the Issuer. F1 · kind: On January 31, 2022, the reporting person was granted performance restricted stock units (PSUs) covering 9,840 shares of the Issuer's common stock, to vest upon the satisfaction of certain performance criteria. On May 2, 2025, 50% of the PSUs vested upon the Issuer's confirmation following the release of its financial results for the quarter ended March 31, 2025 that a performance criterion related to cumulative FILSPARI net revenue had been achieved. F1 · derivative.exercise_date: On January 31, 2022, the reporting person was granted performance restricted stock units (PSUs) covering 9,840 shares of the Issuer's common stock, to vest upon the satisfaction of certain performance criteria. On May 2, 2025, 50% of the PSUs vested upon the Issuer's confirmation following the release of its financial results for the quarter ended March 31, 2025 that a performance criterion related to cumulative FILSPARI net revenue had been achieved. F1 · derivative.expiration_date: On January 31, 2022, the reporting person was granted performance restricted stock units (PSUs) covering 9,840 shares of the Issuer's common stock, to vest upon the satisfaction of certain performance criteria. On May 2, 2025, 50% of the PSUs vested upon the Issuer's confirmation following the release of its financial results for the quarter ended March 31, 2025 that a performance criterion related to cumulative FILSPARI net revenue had been achieved. Read SEC document |
| May 02, 2025 Filed May 6, 2025 01:53 UTC |
Heerma PeterCHIEF COMMERCIAL OFFICER
|
Exercise / conversionCommon Stock | 4,920 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-25-012057 · form4-05062025_010504.xml · nonDerivative · entry 1 Heerma Peter · CIK 0001789617 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 129,986 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: On January 31, 2022, the reporting person was granted performance restricted stock units (PSUs) covering 9,840 shares of the Issuer's common stock, to vest upon the satisfaction of certain performance criteria. On May 2, 2025, 50% of the PSUs vested upon the Issuer's confirmation following the release of its financial results for the quarter ended March 31, 2025 that a performance criterion related to cumulative FILSPARI net revenue had been achieved. F2 · price: Each PSU represents a contingent right to receive one share of the common stock of the Issuer. Read SEC document |
| May 02, 2025 Filed May 6, 2025 01:52 UTC |
ROTE WILLIAM E.Chief Research Officer
|
Exercise / conversionPerformance-based restricted stock units · Derivative | 4,920 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-012056 · form4-05062025_010518.xml · derivative · entry 3 ROTE WILLIAM E. · CIK 0001698262 · Chief Research Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,920 Underlying: Common Stock · 4,920 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each PSU represents a contingent right to receive one share of the common stock of the Issuer. F1 · kind: On January 31, 2022, the reporting person was granted performance restricted stock units (PSUs) covering 9,840 shares of the Issuer's common stock, to vest upon the satisfaction of certain performance criteria. On May 2, 2025, 50% of the PSUs vested upon the Issuer's confirmation following the release of its financial results for the quarter ended March 31, 2025 that a performance criterion related to cumulative FILSPARI net revenue had been achieved. F1 · derivative.exercise_date: On January 31, 2022, the reporting person was granted performance restricted stock units (PSUs) covering 9,840 shares of the Issuer's common stock, to vest upon the satisfaction of certain performance criteria. On May 2, 2025, 50% of the PSUs vested upon the Issuer's confirmation following the release of its financial results for the quarter ended March 31, 2025 that a performance criterion related to cumulative FILSPARI net revenue had been achieved. F1 · derivative.expiration_date: On January 31, 2022, the reporting person was granted performance restricted stock units (PSUs) covering 9,840 shares of the Issuer's common stock, to vest upon the satisfaction of certain performance criteria. On May 2, 2025, 50% of the PSUs vested upon the Issuer's confirmation following the release of its financial results for the quarter ended March 31, 2025 that a performance criterion related to cumulative FILSPARI net revenue had been achieved. Read SEC document |
| May 02, 2025 Filed May 6, 2025 01:52 UTC |
ROTE WILLIAM E.Chief Research Officer
|
Exercise / conversionCommon Stock | 4,920 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-25-012056 · form4-05062025_010518.xml · nonDerivative · entry 1 ROTE WILLIAM E. · CIK 0001698262 · Chief Research Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 103,439 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: On January 31, 2022, the reporting person was granted performance restricted stock units (PSUs) covering 9,840 shares of the Issuer's common stock, to vest upon the satisfaction of certain performance criteria. On May 2, 2025, 50% of the PSUs vested upon the Issuer's confirmation following the release of its financial results for the quarter ended March 31, 2025 that a performance criterion related to cumulative FILSPARI net revenue had been achieved. F2 · price: Each PSU represents a contingent right to receive one share of the common stock of the Issuer. Read SEC document |
| May 02, 2025 Filed May 6, 2025 01:51 UTC |
REED ELIZABETH EChief Legal Officer and GC
|
Exercise / conversionPerformance-based restricted stock units · Derivative | 4,920 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-012054 · form4-05062025_010531.xml · derivative · entry 3 REED ELIZABETH E · CIK 0001283303 · Chief Legal Officer and GC 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,920 Underlying: Common Stock · 4,920 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each PSU represents a contingent right to receive one share of the common stock of the Issuer. F1 · kind: On January 31, 2022, the reporting person was granted performance restricted stock units (PSUs) covering 9,840 shares of the Issuer's common stock, to vest upon the satisfaction of certain performance criteria. On May 2, 2025, 50% of the PSUs vested upon the Issuer's confirmation following the release of its financial results for the quarter ended March 31, 2025 that a performance criterion related to cumulative FILSPARI net revenue had been achieved F1 · derivative.exercise_date: On January 31, 2022, the reporting person was granted performance restricted stock units (PSUs) covering 9,840 shares of the Issuer's common stock, to vest upon the satisfaction of certain performance criteria. On May 2, 2025, 50% of the PSUs vested upon the Issuer's confirmation following the release of its financial results for the quarter ended March 31, 2025 that a performance criterion related to cumulative FILSPARI net revenue had been achieved F1 · derivative.expiration_date: On January 31, 2022, the reporting person was granted performance restricted stock units (PSUs) covering 9,840 shares of the Issuer's common stock, to vest upon the satisfaction of certain performance criteria. On May 2, 2025, 50% of the PSUs vested upon the Issuer's confirmation following the release of its financial results for the quarter ended March 31, 2025 that a performance criterion related to cumulative FILSPARI net revenue had been achieved Read SEC document |
| May 02, 2025 Filed May 6, 2025 01:51 UTC |
REED ELIZABETH EChief Legal Officer and GC
|
Exercise / conversionCommon Stock | 4,920 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-25-012054 · form4-05062025_010531.xml · nonDerivative · entry 1 REED ELIZABETH E · CIK 0001283303 · Chief Legal Officer and GC 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 94,402 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: On January 31, 2022, the reporting person was granted performance restricted stock units (PSUs) covering 9,840 shares of the Issuer's common stock, to vest upon the satisfaction of certain performance criteria. On May 2, 2025, 50% of the PSUs vested upon the Issuer's confirmation following the release of its financial results for the quarter ended March 31, 2025 that a performance criterion related to cumulative FILSPARI net revenue had been achieved F2 · price: Each PSU represents a contingent right to receive one share of the common stock of the Issuer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.